A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33

NCT07590856 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: GPA33-CC；177Lu-SmartD2

Sponsor

SmartNuclide Biopharma

Collaborators

[object Object]